ICD-10-CM Billable Code

F12.980

Cannabis use, unspecified with anxiety disorder

Clinical Classification Guidelines

Inclusion Terms

  • Cannabis induced anxiety disorder, without use disorder

Medical Intelligence & Overview

ICD-10 code F12.980 refers to a condition where an individual uses cannabis and experiences an anxiety disorder without having a cannabis use disorder. This means the person may not be addicted to cannabis, but its use can still trigger anxiety symptoms. Cannabis, also known as marijuana, is a psychoactive drug that affects the brain and body. While some use it for recreational or medicinal purposes, it can sometimes lead to mental health challenges, including anxiety. Recognizing and understanding this condition can help individuals and healthcare providers manage symptoms effectively.

Causes & Symptoms

Clinical Causes: Use of cannabis, especially in higher doses or potent forms Genetic predisposition to anxiety disorders Personal history of anxiety or mood disorders Pre-existing mental health conditions that may be exacerbated by cannabis Environmental stressors or traumatic experiences Biological factors affecting brain chemistry

Key Symptoms: Persistent feelings of worry or fear Restlessness or feeling on edge Muscle tension or physical discomfort Sleep disturbances, such as difficulty falling asleep or staying asleep Rapid heartbeat or increased heart rate Sweating or trembling Difficulty concentrating Feeling of impending doom or panic attacks

Diagnostic & Treatment

Diagnosis Path: Diagnosis of cannabis-induced anxiety disorder involves a thorough mental health evaluation by a healthcare professional. The clinician assesses the patient's history of cannabis use and the onset of anxiety symptoms. They ensure that symptoms are not better explained by other medical or psychiatric conditions. Laboratory tests are typically not used for diagnosis but may be conducted to rule out other causes. The key criterion is that the anxiety distress appears directly related to cannabis consumption and is not accompanied by a cannabis use disorder, which involves problematic use or dependency.

Treatment Protocols: Management of cannabis-induced anxiety disorder generally involves several approaches: - **Cessation or reduction of cannabis use** to eliminate triggers - **Psychotherapy**, such as cognitive-behavioral therapy (CBT), to develop coping strategies for anxiety - **Medication** may be considered in severe cases, prescribed by a healthcare provider, such as anxiolytics or antidepressants - **Lifestyle changes**, including stress management techniques, regular physical activity, and mindfulness practices - **Support groups or counseling** to address underlying mental health issues or emotional challenges It is crucial for individuals experiencing these symptoms to seek professional advice to determine the most appropriate plan aimed at reducing anxiety and improving overall mental health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F12.980 a billable ICD-10 code?
Yes, F12.980 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F12.980?
Clinical documentation must specify the nature of Cannabis use, unspecified with anxiety disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference